Literature DB >> 7381023

An evaluation of commercial radioisotope methods for the determination of folate and vitamin B12.

D W Dawson, I W Delamore, D I Fish, T A Flaherty, A H Gowenlock, L P Hunt, K Hyde, J E MacIver, J A Thornton, H M Waters.   

Abstract

Five commercial kits for the determination of folate and six kits for the determination of vitamin B12 were investigated. Their performance has been compared with microbiological methods for the two vitamins and with a non-commercial radioisotopic method for B12. The results show the importance of the determination of the reference range for an individual laboratory for each method. The precision of the kits varied appreciably, as did their performance using specimens from patients with different haematological disorders. In particular, certain kits failed to detect all patients with pernicious anaemia. The relative accuracy of the kits was assessed. Various factors which should be taken into account in the final selection of a satisfactory kit are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381023      PMCID: PMC1146046          DOI: 10.1136/jcp.33.3.234

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum.

Authors:  B A Cooper; V M Whitehead
Journal:  N Engl J Med       Date:  1978-10-12       Impact factor: 91.245

2.  A simple routine radioisotope method for the estimation of serum vitamin B12 using DEAE cellulose and human serum binding agent.

Authors:  M Wagstaff; A Broughton
Journal:  Br J Haematol       Date:  1971-11       Impact factor: 6.998

3.  Experience with a simplified method of radio-isotopic assay of serum vitamin B 12.

Authors:  R P Britt; F G Bolton; A C Cull; G H Spray
Journal:  Br J Haematol       Date:  1969-05       Impact factor: 6.998

4.  An automated method for the measurement of folate activity.

Authors:  R E Davis; D J Nicol; A Kelly
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

5.  Results with radioisotopic assay of serum B12 using serum binding agent.

Authors:  D M Matthews; R Gunasegaram; J C Linnell
Journal:  J Clin Pathol       Date:  1967-09       Impact factor: 3.411

6.  Evaluation of a commercial radioisotopic kit for folate assays.

Authors:  P W Hill; D W Dawson
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

7.  Measurement of serum folate: experience with 75Se-selenofolate radioassay.

Authors:  I Johnson; H Guilford; M Rose
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

8.  Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii.

Authors:  J L Raven; M B Robson; J O Morgan; A V Hoffbrand
Journal:  Br J Haematol       Date:  1972-01       Impact factor: 6.998

9.  Comparison of commercial kits for radioimmunoassay: III. Radioassay of serum folate.

Authors:  N P Kubasik; M T Volosin; H E Sine
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

10.  Experience with a commercial kit for the radioisotopic assay of vitamin B12 in serum: the Phadebas B12 test.

Authors:  J L Raven; M B Robson
Journal:  J Clin Pathol       Date:  1974-01       Impact factor: 3.411

View more
  3 in total

1.  Evaluation of a commercial radioassay for the simultaneous estimation of vitamin B12 and folate, with subsequent derivation of the normal reference range.

Authors:  E Raniolo; G Phillipou; G Paltridge; R E Sage
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

2.  Comparative studies of a new commercial kit for the estimation of vitamin B12 in serum.

Authors:  H M Waters; J A Thornton; R F Stevens; A H Gowenlock; J E Maciver; I W Delamore
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

Review 3.  Hematologic disorders in the elderly.

Authors:  J R Walsh
Journal:  West J Med       Date:  1981-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.